Therapeutic impact of 18F-FDG PET/CT in recurrent differentiated thyroid carcinoma

被引：0
|
作者：
Fabio Pomerri
Anna Rita Cervino
Faise Al Bunni
Laura Evangelista
Pier Carlo Muzzio
机构：
[1] Veneto Institute of Oncology IOV-IRCCS,Department of Medicine
[2] Oncologic Radiology Unit,undefined
[3] University of Padua,undefined
[4] Veneto Institute of Oncology IOV-IRCCS,undefined
[5] Radiotherapy and Nuclear Medicine Unit,undefined
来源：
La radiologia medica | 2014年 / 119卷
关键词：
Thyroid carcinoma; Positron emission tomography/computed tomography; Thyroglobulin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：97 / 102
页数：5
相关论文
共 50 条
  • [1] Therapeutic impact of 18F-FDG PET/CT in recurrent differentiated thyroid carcinoma
    Pomerri, Fabio
    Cervino, Anna Rita
    Al Bunni, Faise
    Evangelista, Laura
    Muzzio, Pier Carlo
    RADIOLOGIA MEDICA, 2014, 119 (02): : 97 - 102
  • [2] 18F-FDG PET/CT IN DIFFERENTIATED THYROID CARCINOMA
    Larg, M. I.
    Barbus, E.
    Gabora, K.
    Pestean, C.
    Cheptea, M.
    Piciu, D.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2019, 15 (02) : 203 - 208
  • [3] Role of 18F-FDG PET/CT in differentiated thyroid carcinoma
    Craciun, D.
    Alexa, M.
    Mazilu, C.
    Mazilu, A.
    Oancea, M.
    Goldstein, A.
    Voicu, G.
    Neagu, D.
    Chiriac, I.
    Mititelu, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S559 - S560
  • [4] The clinical impact of 18F-FDG gamma PET in patients with recurrent well differentiated thyroid carcinoma
    Goshen, E
    Cohen, O
    Rotenberg, G
    Oksman, Y
    Karasik, A
    Zwas, ST
    NUCLEAR MEDICINE COMMUNICATIONS, 2003, 24 (09) : 959 - 961
  • [5] The Use of 18F-FDG PET/CT in Patients with Recurrent Differentiated Thyroid Cancer
    Ekmekcioglu, Ozgul
    MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, 2021, 30 (03) : 137 - 143
  • [6] The clinical impact of 18F-FDG gamma PET in patients with recurrent well differentiated thyroid carcinoma.
    Goshen, E
    Zwas, ST
    Cohen, O
    Rotenberg, G
    Oksman, Y
    Karasik, A
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 328P - 328P
  • [7] 18F-FDG PET/CT impact on the management of papillary thyroid carcinoma
    Dennis, K. E. B.
    Hay, J. H.
    Wilson, D. C.
    RADIOTHERAPY AND ONCOLOGY, 2007, 84 : S49 - S50
  • [8] Usefulness of 18F-FDG PET/CT in thyroid carcinoma
    Muros de Fuentes, M. A.
    Mitjavila Casanovas, M.
    Estorch Cabrera, M.
    Lecumberri Santamaria, B.
    Navarro Gonzalez, E.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2016, 35 (03): : 186 - 192
  • [9] IMPACT OF 18F-FDG PET/CT-GUIDED TREATMENT FOR SUSPECTED RECURRENT PAPILLARY THYROID CARCINOMA
    Dennis, K.
    Hay, J.
    Wilson, D.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S56 - S56
  • [10] 18F-FDG PET in recurrent medullary thyroid carcinoma.
    Bruno, A
    Castellani, M
    Verga, U
    Schiavini, M
    Leo, R
    Gerundini, P
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 322P - 322P
12345